Cargando…
A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...
Autores principales: | Hamid, Mohsin, Lashari, Bilal, Ahsan, Irfan, Micaily, Ida, Sarwar, Usman, Crocetti, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998292/ https://www.ncbi.nlm.nih.gov/pubmed/29915656 http://dx.doi.org/10.1080/20009666.2018.1466598 |
Ejemplares similares
-
Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
por: Hamid, Mohsin, et al.
Publicado: (2018) -
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020) -
Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
por: Al-Jasser, Asma Marzouq
Publicado: (2006) -
Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH
por: Marak, Creticus, et al.
Publicado: (2022) -
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)